Bml Capital Management, LLC Forte Biosciences, Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 1,761,702 shares of FBRX stock, worth $1.06 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
1,761,702
Previous 1,761,702
-0.0%
Holding current value
$1.06 Million
Previous $1.45 Billion
15.27%
% of portfolio
0.82%
Previous 1.1%
Shares
3 transactions
Others Institutions Holding FBRX
# of Institutions
34Shares Held
19MCall Options Held
1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$2.17 Million0.57% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$1.96 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$1.79 Million0.06% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$1.22 Million1.95% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$1.1 Million0.01% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $12.2M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.